Highlights

  • On 21 July the company announced the date of its second-quarter results and an accompanying webinar.
  • Atomera reported second-quarter 2026 results on 4 August through a PR Newswire release, which StockAnalysis lists alongside the quarterly.
  • To put the scale in perspective, the trailing net loss of $22.41 million is roughly 97 times trailing revenue.
  • The most recent prices we could verify are from StockAnalysis, whose history showed closes of $4.37 on 7 October.

Atomera (NASDAQ:ATOM) is a semiconductor materials and technology company that seeks to licence its technology to chipmakers rather than manufacture chips itself. That model means reported revenue can be very small while customers evaluate and qualify the technology. The company's latest financial data illustrate this. StockAnalysis shows revenue of $65,000 and a net loss of $20.17 million for fiscal 2025, and trailing-twelve-month revenue of $230,000 with a net loss of $22.41 million.

Those figures describe a company whose spending is far larger than its sales, which is why its funding position and the pace of customer adoption matter more to many investors than the income statement alone.

Latest company news

Atomera reported second-quarter 2026 results on 4 August through a PR Newswire release, which StockAnalysis lists alongside the quarterly report and slides. A transcript summary on the same page described revenue as modest, costs as rising and the company as posting a net loss, with strong cash reserves. The page did not give specific quarterly revenue, loss or cash figures, so none are stated here.

On 21 July the company announced the date of its second-quarter results and an accompanying webinar. On 4 June it announced GaN-on-silicon radio-frequency technology through Business Wire. StockAnalysis also notes that Atomera closed a $25 million registered direct offering in February 2026, which it links to the company's cash position.

Why the funding matters

To put the scale in perspective, the trailing net loss of $22.41 million is roughly 97 times trailing revenue of $230,000, a ratio we calculated from the data provider's figures. Such a gap also means the shares are priced largely on expectations of future licensing rather than current sales.

A registered direct offering is a sale of new shares to selected investors, which adds cash but increases the number of shares outstanding. With a net loss of $22.41 million over the trailing twelve months, simple arithmetic suggests the $25 million raised would cover roughly a year of losses at that rate if no other cash were available. That is based on the reported figures and ignores existing cash, which the sources do not quantify, so it is not a statement about the company's runway.

Share price and benchmark

The most recent prices we could verify are from StockAnalysis, whose history showed closes of $4.37 on 7 October, $4.13 on 8 October, $4.16 on 9 October and $3.91 on 12 October 2026. The page also showed an intraday price of $3.80 on 13 October at about 10:05 a.m. Eastern Time, which is not a close. The market capitalisation shown was about $160 million, which makes Atomera a very small company by listed-equity standards. The 12 October close was about 10.5% below the 7 October close, a change we calculated, and the sources do not identify a cause.

The Nasdaq Composite is used only as a benchmark.

What to watch next

StockAnalysis estimates the next earnings report for 27 October 2026, although Investors may look for any change in revenue from licensing, the level of cash against the net loss, and any update on customer programmes. Additional share issuance would also affect existing holders. The company's own release will provide authoritative figures.